Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma
GermanyStudy on the Safety and Effectiveness of NMD670 for Adults with Charcot-Marie-Tooth Disease Types 1 and 2
BelgiumStudy on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease
BelgiumStudy on Botulinum Toxin Type A for Patients with Treatment-Resistant Chronic Migraine
NorwayStudy on the Safety and Tolerability of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyStudy on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis
PolandStudy of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation
FranceStudy on Early Temozolomide Treatment for Adults with Glioblastoma
BelgiumStudy to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria
FranceStudy of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma
FranceStudy of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months
FranceStudy on the Safety and Effectiveness of LT3001 for Patients with Acute Ischemic Stroke
CzechiaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
